Who owns Ionis Pharmaceuticals (IONS)? Superinvestor holders

4 superinvestors of the 157 tracked here hold Ionis Pharmaceuticals (IONS) in their latest 13F filing, with $584M between them. Tweedy, Browne team gives it the most weight: 6.52% of the reported portfolio. In their latest reported quarter, Cathie Wood and John Overdeck and David Siegel (founders) added; Tweedy, Browne team reduced.

Ron Baron sold out of it in their latest quarter.

Hold it now
4
of 157 tracked
Combined value
$584M
Bought / sold
2 / 2
last quarter

Key facts

Superinvestors holding it
4 of 157
Biggest holder
John Overdeck and David Siegel (founders), $300.4M
Largest weight
Tweedy, Browne team, 6.52%of their portfolio
Combined value
$584M
Bought last quarter
2
Sold last quarter
2

From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.

Superinvestors holding IONS, latest filings
#InvestorShare of their portfolioValueSharesLast quarterShares movedQuarter
1Tweedy, Browne teamTweedy, Browne Company6.52%$80.1M1.79M▼ Reduced 21%−486.83KQ3 2026
2Julian and Felix BakerBaker Bros. Advisors0.81%$162.4M2.05MNo change0Q2 2026
3Cathie WoodARK Invest0.24%$41.2M923.16K▲ Added 207%+622.39KQ3 2026
4John Overdeck and David Siegel (founders)Two Sigma Investments0.22%$300.4M6.73M▲ Added 7.6%+475.17KQ3 2026

Sold out last quarter

Quarter by quarter

Superinvestor ownership of IONS by quarter
QuarterFilings inHoldersCombined sharesCombined valueBoughtSold
Q3 20269239.44M$421.7M22
Q2 2026157410.88M$862.8M30
Q1 2026157510.47M$786.5M22
Q4 202515757.34M$580.9M22
Q3 202515744.1M$268.5M31
Q2 202515723.79M$149.8M03
Q1 202515634.34M$131M02
Q4 202415634.63M$161.9M13

A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.

Each holder's shares

Shares of IONS held by each superinvestor, by quarter
InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
John Overdeck and David Siegel (founders)6.73M6.25M5.86M2.66M————
Tweedy, Browne team1.79M2.28M2.28M2.46M2.9M2.89M2.98M3.25M
Cathie Wood923.16K300.77K288.72K422.97K631.22K900.32K1M1.03M
Julian and Felix Baker·2.05M2.05M1.79M566.8K—357.92K357.92K
Andrew Spokes——4.8K4.8K4.8K———

A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.

Questions and answers

Which superinvestors own IONS?

In their latest 13F filings: Tweedy, Browne team (6.52% of the portfolio, $80.1M), Julian and Felix Baker (0.81% of the portfolio, $162.4M), Cathie Wood (0.24% of the portfolio, $41.2M), John Overdeck and David Siegel (founders) (0.22% of the portfolio, $300.4M).

Who bought IONS last quarter?

Cathie Wood (added 207%), John Overdeck and David Siegel (founders) (added 7.6%). “Last quarter” is each investor's latest reported quarter.

Who sold IONS last quarter?

Reduced: Tweedy, Browne team (21% fewer shares). Sold out entirely: Ron Baron (was $1.1M).

How current is this?

It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.

Learn

Cite this page

Funkfolio, “Who owns Ionis Pharmaceuticals (IONS)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/IONS/superinvestors

Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.

Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to IONS by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.